Works by Mundhenke, Christoph


Results: 40
    1
    2
    3

    Physical activity levels are positively related to progression-free survival and reduced adverse events in advanced ER<sup>+</sup> breast cancer.

    Published in:
    BMC Medicine, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12916-024-03671-x
    By:
    • Zimmer, Philipp;
    • Esser, Tobias;
    • Lueftner, Diana;
    • Schuetz, Florian;
    • Baumann, Freerk T.;
    • Rody, Achim;
    • Schneeweiss, Andreas;
    • Hartkopf, Andreas D.;
    • Decker, Thomas;
    • Uleer, Christoph;
    • Stoetzer, Oliver J.;
    • Foerster, Frank;
    • Schmidt, Marcus;
    • Mundhenke, Christoph;
    • Steindorf, Karen;
    • Tesch, Hans;
    • Jackisch, Christian;
    • Fischer, Thomas;
    • Hanson, Sven;
    • Kreuzeder, Julia
    Publication type:
    Article
    4

    The impact of physical activity on progression-free and overall survival in metastatic breast cancer based on molecular subtype.

    Published in:
    BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-13038-3
    By:
    • Ziegler, Philipp;
    • Hartkopf, Andreas D.;
    • Wallwiener, Markus;
    • Häberle, Lothar;
    • Kolberg, Hans-Christian;
    • Hadji, Peyman;
    • Tesch, Hans;
    • Ettl, Johannes;
    • Lüftner, Diana;
    • Müller, Volkmar;
    • Michel, Laura L.;
    • Belleville, Erik;
    • Wimberger, Pauline;
    • Hielscher, Carsten;
    • Huebner, Hanna;
    • Uhrig, Sabrina;
    • Wurmthaler, Lena A.;
    • Hack, Carolin C.;
    • Mundhenke, Christoph;
    • Kurbacher, Christian
    Publication type:
    Article
    5
    6
    7
    8

    Monitoring serum HER2 levels during neoadjuvant trastuzumab treatment within the GeparQuattro trial.

    Published in:
    Breast Cancer Research & Treatment, 2010, v. 123, n. 2, p. 437, doi. 10.1007/s10549-010-1030-9
    By:
    • Witzel, Isabell;
    • Loibl, Sibylle;
    • Minckwitz, Gunter;
    • Mundhenke, Christoph;
    • Huober, Jens;
    • Hanusch, Claus;
    • Henschen, Stephan;
    • Hauschild, Maik;
    • Lantzsch, Tilmann;
    • Tesch, Hans;
    • Latos, Kunibert;
    • Just, Marianne;
    • Hilfrich, Jörn;
    • Barinoff, Jana;
    • Eulenburg, Christine;
    • Roller, Marc;
    • Untch, Michael;
    • Müller, Volkmar
    Publication type:
    Article
    9
    10
    11
    12

    Everolimus as treatment for breast cancer patients with bone metastases only: results of the phase II RADAR study.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2013, v. 139, n. 12, p. 2047, doi. 10.1007/s00432-013-1518-x
    By:
    • Maass, Nicolai;
    • Harbeck, Nadia;
    • Mundhenke, Christoph;
    • Lerchenmüller, Christian;
    • Barinoff, Jana;
    • Lück, Hans-Joachim;
    • Ettl, Johannes;
    • Aktas, Bahriye;
    • Kümmel, Sherko;
    • Rösel, Siegfried;
    • Wagner, Steffen;
    • Müller, Lothar;
    • Bischoff, Joachim;
    • Lübbe, Kristina;
    • Schwedler, Kathrin;
    • Schmidt, Marcus;
    • Bauerschlag, Dirk;
    • Nekljudova, Valentina;
    • von Minckwitz, Gunter;
    • Loibl, Sibylle
    Publication type:
    Article
    13
    14
    15

    Reply to letter by Dr. G. Corso.

    Published in:
    2018
    By:
    • Stuebs, Frederik;
    • Heidemann, Simone;
    • Caliebe, Almuth;
    • Mundhenke, Christoph;
    • Arnold, Norbert
    Publication type:
    Letter
    16
    17
    18
    19
    20
    21
    22

    Predicting Prognosis of Breast Cancer Patients with Brain Metastases in the BMBC Registry—Comparison of Three Different GPA Prognostic Scores.

    Published in:
    Cancers, 2021, v. 13, n. 4, p. 844, doi. 10.3390/cancers13040844
    By:
    • Riecke, Kerstin;
    • Müller, Volkmar;
    • Weide, Rudolf;
    • Schmidt, Marcus;
    • Park-Simon, Tjoung-Won;
    • Möbus, Volker;
    • Mundhenke, Christoph;
    • Polasik, Arkadius;
    • Lübbe, Kristina;
    • Hesse, Tobias;
    • Laakmann, Elena;
    • Thill, Marc;
    • A. Fasching, Peter;
    • Denkert, Carsten;
    • Fehm, Tanja;
    • Nekljudova, Valentina;
    • Rey, Julia;
    • Loibl, Sibylle;
    • Witzel, Isabell;
    • Lo, Simon S.
    Publication type:
    Article
    23

    Progression-Free Survival and Overall Survival in Patients with Advanced HER2-Positive Breast Cancer Treated with Trastuzumab Emtansine (T-DM1) after Previous Treatment with Pertuzumab.

    Published in:
    Cancers, 2020, v. 12, n. 10, p. 3021, doi. 10.3390/cancers12103021
    By:
    • Michel, Laura L.;
    • Hartkopf, Andreas D.;
    • Fasching, Peter A.;
    • Kolberg, Hans-Christian;
    • Hadji, Peyman;
    • Tesch, Hans;
    • Häberle, Lothar;
    • Ettl, Johannes;
    • Lüftner, Diana;
    • Wallwiener, Markus;
    • Müller, Volkmar;
    • Beckmann, Matthias W.;
    • Belleville, Erik;
    • Volz, Bernhard;
    • Huebner, Hanna;
    • Wimberger, Pauline;
    • Hielscher, Carsten;
    • Mundhenke, Christoph;
    • Kurbacher, Christian;
    • Wuerstlein, Rachel
    Publication type:
    Article
    24

    Characteristics and Clinical Outcome of Breast Cancer Patients with Asymptomatic Brain Metastases.

    Published in:
    Cancers, 2020, v. 12, n. 10, p. 2787, doi. 10.3390/cancers12102787
    By:
    • Laakmann, Elena;
    • Witzel, Isabell;
    • Neunhöffer, Tanja;
    • Weide, Rudolf;
    • Schmidt, Marcus;
    • Park-Simon, Tjoung-Won;
    • Möbus, Volker;
    • Mundhenke, Christoph;
    • Polasik, Arkadius;
    • Lübbe, Kristina;
    • Hesse, Tobias;
    • Riecke, Kerstin;
    • Thill, Marc;
    • Fasching, Peter A.;
    • Denkert, Carsten;
    • Fehm, Tanja;
    • Nekljudova, Valentina;
    • Rey, Julia;
    • Loibl, Sibylle;
    • Müller, Volkmar
    Publication type:
    Article
    25

    Clinical Relevance of Collagen Protein Degradation Markers C3M and C4M in the Serum of Breast Cancer Patients Treated with Neoadjuvant Therapy in the GeparQuinto Trial.

    Published in:
    Cancers, 2019, v. 11, n. 8, p. 1186, doi. 10.3390/cancers11081186
    By:
    • Banys-Paluchowski, Malgorzata;
    • Loibl, Sibylle;
    • Witzel, Isabell;
    • Mundhenke, Christoph;
    • Lederer, Bianca;
    • Solbach, Christine;
    • Karn, Thomas;
    • Marmé, Frederik;
    • Nekljudova, Valentina;
    • Schem, Christian;
    • Stickeler, Elmar;
    • Willumsen, Nicholas;
    • Karsdal, Morten A.;
    • Untch, Michael;
    • Müller, Volkmar
    Publication type:
    Article
    26
    27

    Efficacy and safety of everolimus plus exemestane in postmenopausal women with hormone receptor‐positive, human epidermal growth factor receptor 2‐negative locally advanced or metastatic breast cancer: Results of the single‐arm, phase IIIB 4EVER trial

    Published in:
    International Journal of Cancer, 2019, v. 144, n. 4, p. 877, doi. 10.1002/ijc.31738
    By:
    • Tesch, Hans;
    • Stoetzer, Oliver;
    • Decker, Thomas;
    • Kurbacher, Christian M.;
    • Marmé, Frederik;
    • Schneeweiss, Andreas;
    • Mundhenke, Christoph;
    • Distelrath, Andrea;
    • Fasching, Peter A.;
    • Lux, Michael P.;
    • Lüftner, Diana;
    • Hadji, Peyman;
    • Janni, Wolfgang;
    • Muth, Mathias;
    • Kreuzeder, Julia;
    • Quiering, Claudia;
    • Taran, Florin‐Andrei
    Publication type:
    Article
    28
    29
    30
    31

    The risk of contralateral breast cancer in patients from BRCA1/2 negative high risk families as compared to patients from BRCA1 or BRCA2 positive families: a retrospective cohort study.

    Published in:
    2012
    By:
    • Rhiem, Kerstin;
    • Engel, Christoph;
    • Graeser, Monika;
    • Zachariae, Silke;
    • Kast, Karin;
    • Kiechle, Marion;
    • Ditsch, Nina;
    • Janni, Wolfgang;
    • Mundhenke, Christoph;
    • Golatta, Michael;
    • Varga, Dominic;
    • Preisler-Adams, Sabine;
    • Heinrich, Tilman;
    • Bick, Ulrich;
    • Gadzicki, Dorothea;
    • Briest, Susanne;
    • Meindl, Alfons;
    • Schmutzler, Rita K
    Publication type:
    journal article
    32
    33

    Efficacy and safety of everolimus plus exemestane in patients with hormone receptor‐positive, HER‐2‐negative advanced breast cancer: Results from the open‐label, multicentre, non‐interventional BRAWO study.

    Published in:
    International Journal of Cancer, 2024, v. 155, n. 1, p. 128, doi. 10.1002/ijc.34912
    By:
    • Lüftner, Diana;
    • Schuetz, Florian;
    • Schneeweiss, Andreas;
    • Hartkopf, Andreas;
    • Bloch, Wilhelm;
    • Decker, Thomas;
    • Uleer, Christoph;
    • Stötzer, Oliver;
    • Foerster, Frank;
    • Schmidt, Marcus;
    • Mundhenke, Christoph;
    • Tesch, Hans;
    • Jackisch, Christian;
    • Fischer, Thomas;
    • Kreuzeder, Julia;
    • Guderian, Gernot;
    • Fasching, Peter A.
    Publication type:
    Article
    34

    Neutrophil Gelatinase-Associated Lipocalin (NGAL) Predicts Response to Neoadjuvant Chemotherapy and Clinical Outcome in Primary Human Breast Cancer.

    Published in:
    PLoS ONE, 2012, v. 7, n. 10, p. 1, doi. 10.1371/journal.pone.0045826
    By:
    • Wenners, Antonia Sophie;
    • Mehta, Keyur;
    • Loibl, Sibylle;
    • Park, Hyerim;
    • Mueller, Berit;
    • Arnold, Norbert;
    • Hamann, Sigrid;
    • Weimer, Joerg;
    • Ataseven, Beyhan;
    • Darb-Esfahani, Silvia;
    • Schem, Christian;
    • Mundhenke, Christoph;
    • Khandan, Fariba;
    • Thomssen, Christoph;
    • Jonat, Walter;
    • Holzhausen, Hans-Juergen;
    • von Minckwitz, Gunther;
    • Denkert, Carsten;
    • Bauer, Maret
    Publication type:
    Article
    35
    36
    37
    38

    Book Reviewes · Bücher.

    Published in:
    Breast Care, 2008, v. 3, n. 1, p. 68, doi. 10.1159/000120419
    By:
    • Mundhenke, Christoph
    Publication type:
    Article
    39

    Duktales Carcinoma in situ (DCIS).

    Published in:
    Breast Care, 2006, v. 1, n. 5, p. 328, doi. 10.1159/000096115
    By:
    • Jakisch, Christoph;
    • Jonat, Walter;
    • Mundhenke, Christoph;
    • Marth, Christian;
    • Stierer, Michael;
    • Tulusan, Augustinus H.
    Publication type:
    Article
    40